BP11

omalizumab biosimilar

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BP11, covering 2025-06-05 to 2025-06-05. Get the full timeline:

Most recent: Clinical Trial Update: Biosimilar Study Comparing PK, PD, Safety and Immunogencity of BP11 With US Licensed Xolair and EU Approved Xolair [Phase 1]

See pricing